Active Melanoma Brain Metastases
1 clinical trials · Condition
◉ Watch Active Melanoma Brain Metastases
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases (NCT02230306) | Melissa Burgess, MD | 2015-02-01 |
Track Active Melanoma Brain Metastases automatically
Every clearance here is in the API, with alerts when new ones post.